W Victoria Lai

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Small Cell Lung Cancer

Long Noncoding Rna

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Noura J Choudhury, W Victoria Lai, Alex Makhnin, Glenn Heller, Juliana Eng, Bob T Li, Isabel R Preeshagul, Fernando C Santini, Michael D Offin, Kenneth Ng, Paul K Paik, Christina Larsen, Michelle S Ginsberg, Yvonne Lau, Xinyuan Zhang, Marina K Baine, Natasha Rekhtman, Charles M Rudin
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Noura J Choudhury, W Victoria Lai, Alex Makhnin, Glenn Heller, Juliana Eng, Bob T Li, Isabel R Preeshagul, Fernando C Santini, Michael D Offin, Kenneth Ng, Paul K Paik, Christina Larsen, Michelle S Ginsberg, Yvonne Lau, Xinyuan Zhang, Marina K Baine, Natasha Rekhtman, Charles M Rudin
A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Noura J Choudhury, W Victoria Lai, Alex Makhnin, Glenn Heller, Juliana Eng, Bob T Li, Isabel R Preeshagul, Fernando C Santini, Michael D Offin, Kenneth Ng, Paul K Paik, Christina Larsen, Michelle S Ginsberg, Yvonne Lau, Xinyuan Zhang, Marina K Baine, Natasha Rekhtman, Charles M Rudin
A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Luis G Paz-Ares, Stephane Champiat, W Victoria Lai, Hiroki Izumi, Ramaswamy Govindan, Michael J Boyer, Horst-Dieter Hummel, Hossein Borghaei, Melissa Lynne Johnson, Neeltje Steeghs, Fiona Blackhall, Afshin Dowlati, Noemí Reguart, Tatsuya Yoshida, Kai He, Shirish M Gadgeel, Enriqueta Felip Font, Yiran Zhang, Amrita Pati, Mukul Minocha, Sujoy Mukherjee, Amanda Goldrick, Dirk Nagorsen, Nooshin Hashemi Sadraei, Taofeek Kunle Owonikoko
Tarlatamab, a First-In-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small Cell Lung Cancer: An Open-Label, Phase I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Luis G Paz-Ares, Stephane Champiat, W Victoria Lai, Hiroki Izumi, Ramaswamy Govindan, Michael J Boyer, Horst-Dieter Hummel, Hossein Borghaei, Melissa Lynne Johnson, Neeltje Steeghs, Fiona Blackhall, Afshin Dowlati, Noemí Reguart, Tatsuya Yoshida, Kai He, Shirish M Gadgeel, Enriqueta Felip Font, Yiran Zhang, Amrita Pati, Mukul Minocha, Sujoy Mukherjee, Amanda Goldrick, Dirk Nagorsen, Nooshin Hashemi Sadraei, Taofeek Kunle Owonikoko
Tarlatamab, a first-in-class DLL3-targeted bispecific T cell engager, in recurrent small-cell lung cancer: an open-label, phase 1 study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)